| Literature DB >> 30991700 |
Simona Piccolella1, Alessandro Bianco2, Giuseppina Crescente3, Alessandra Santillo4, Gabriella Chieffi Baccari5, Severina Pacifico6.
Abstract
Food-waste is produced throughout all the food supply chain, with a large part already achieved at farm level. In fact, fruits and vegetables, which do not satisfy aesthetic demands, cannot be marketed, but their recovery could favour their valorisation for the obtainment of highly qualified goods. In this context, faulty zucchini fruits (cultivar 'Lungo Fiorentino'), intended for disposal, were rescued as effective, inexpensive and bio-sustainable source for cosmeceutical purposes. Zucchini fruits underwent extraction and fractionation to obtain ZLF-O and ZLF-A extracts, which were chemically characterized by UHPLC-HRMS. ZLF-A extract, rich in flavonols and flavones, scavenged massively DPPH• and ABTS•+, and was not cytotoxic at doses up to 200 μ g/mL. Thus, ZLF-A was incorporated into a base cream formula. Zucchini-based emulsion was deeply screened for its antiradical properties and cytotoxicity towards human keratinocytes and fibroblasts. ZLF-A-enriched cream, whose chemical stability was assessed over time and mimicking different storage conditions, was further tested on reconstructed epidermis disks (EpiskinTM). The recovery of valuable chemical substances from zucchini agro-food waste, complying with the principles of valorisation and sustainable development, can represent a new market force for local farmers. Data acquired were eager to convey a suitable reuse of nutraceuticals rich zucchini waste.Entities:
Keywords: Cucurbita pepo cv. ‘Lungo Fiorentino’; UHPLC-HRMS; cosmeceutical valorisation; food waste; polyphenols
Mesh:
Substances:
Year: 2019 PMID: 30991700 PMCID: PMC6514934 DOI: 10.3390/molecules24081479
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
TOF and TOF-MS2 data of compounds tentatively identified in ZLF-A fraction.
| Peak n. | Rt (min) | Tentative Assignment | Formula | [M−H]− Found | [M−H]− Calc. ( | Error | RDB | MS/MS Fragment Ions ( |
|---|---|---|---|---|---|---|---|---|
|
| 8.80 | Myricetin 3- | C21H20O13 | 479.0826 | 479.0831 | −1.0 | 12 | 317.0313; 316.0218; 287.0194; 271.0234; 259.0247 |
|
| 9.33 | Quercetin 3- | C33H40O20 | 755.2025 | 755.2040 | −2.0 | 14 | 609.1484; 591.1386; 489.1059; 301.0355; 300.0277; 271.0246; 255.0297; 178.9985 |
|
| 9.71 | Quercetin 3- | C26H28O16 | 595.1303 | 595.1304 | −0.2 | 13 | 301.0350; 300.0279; 287.0578; 271.0249; 255.0292 |
|
| 10.64 | Kaempferol 3- | C33H40O19 | 739.2066 | 739.2091 | −3.4 | 14 | 575.1429; 285.0406; 284.0325; 255.0300; 227.0350 |
|
| 10.72 | Rutin | C27H30O16 | 609.1462 | 609.1461 | −0.2 | 13 | 343.0461; 301.0351; 300.0271; 271.0245; 255.0298; 243.0297; 178.9980; 151.0031 |
|
| 10.97 | Quercetin 3- | C21H20O12 | 463.0876 | 463.0882 | 1.3 | 12 | 301.0360; 300.0280; 271.0252; 255.0302; 243.0297; 151.0032 |
|
| 10.98 | Isorhamnetin | C34H42O20 | 769.2183 | 769.2197 | −1.8 | 14 | 605.1556; 315.0514; 314.0439; 299.0204; 271.0252; 243.0301 |
|
| 11.19 | Luteolin hexoside | C21H20O11 | 447.0925 | 447.0933 | −1.8 | 12 | 285.0395; 284.0314 |
|
| 11.20 | Luteolin | C27H30O15 | 593.1506 | 593.1512 | −1.0 | 13 | 285.0404; 284.0314 |
|
| 11.36 | Kaempferol hexosyl-deoxyhexoside (isomer 1) | C27H30O15 | 593.1514 | 593.1512 | 0.3 | 13 | 473.1109; 447.0953; 429.0826; 327.0503; 285.0395; 284.0322; 255.0292; 227.0341; 178.9978; 151.0037 |
|
| 11.41 | Kaempferol 3- | C26H28O15 | 579.1358 | 579.1355 | 0.4 | 13 | 357.1471; 285.0387; 284.0315; 255.0287; 227.0331 |
|
| 11.65 | Isorhamnetin 4′- | C28H32O16 | 623.1619 | 623.1618 | 0.2 | 13 | 477.1032; 459.0941; 443.2295; 357.0613; 339.0506; 315.0505; 314.0428; 299.0188; 285.0386; 271.0238; 255.0287; 243.0292; 227.0332; 199.0390; 178.9975; 151.0021 |
|
| 12.27 | Kaempferol hexosyl-deoxyhexoside (isomer 2) | C27H30O15 | 593.1520 | 593.1512 | 1.4 | 13 | 327.0513; 285.0404; 284.0327; 257.0455; 255.0299; 227.0351 |
|
| 12.27 | Kaempferol 3- | C21H20O11 | 447.0924 | 447.0933 | −2.4 | 12 | 285.0392; 284.0326; 257.0437; 255.0302; 227.0342 |
|
| 12.60 | Isorhamnetin 7- | C28H32O16 | 623.1620 | 623.1618 | 0.4 | 13 | 357.0623; 315.0514; 314.0438; 300.0282; 299.0188; 285.0409; 271.0253; 255.0300; 243.0304 |
|
| 13.31 | Anthraquinone derivative 1 | C34H36O17 | 715.1893 | 715.1880 | 1.8 | 17 | 621.1469; 407.0773; 406.0694; 313.0346; 312.0269; 285.0381; 283.0243 |
|
| 13.53 | Anthraquinone derivative 2 | C34H36O16 | 699.1942 | 699.1931 | 1.6 | 17 | 605.1517; 391.0806; 390.0731; 333.0745; 297.0385; 296.0304; 269.0432; 267.0276 |
|
| 13.73 | Ent-kaurene diterpene glycoside | C38H60O18 | 803.3713 | 803.3707 | 0.8 | 9 | 641.3231 (→479.2690; 461.2578; 335.2240; 317.2119); 623.3117; 479.2673; 413.2344; 317.2129 |
Rt = retention time; [M−H] found (m/z) = deprotonated ions experimentally observed in TOF-MS spectra (m/z of the monoisotopic peaks); [M−H]− calc. (m/z) = theoretical deprotonated ions for a given molecular formula (m/z of the monoisotopic peaks); error (ppm) = mass error of an assignment, obtained comparing a theoretical m/z and an experimentally observed m/z (accepted values < 5 ppm); RDB = Rings and Double Bonds (conventional measure of the degree of unsaturation).
TOF-MS and TOF-MS2 data of compounds putatively identified in ZLF-O fraction.
| Peak n. | Rt (min) | Tentative Assignment | Formula | [M−H]− Found | [M−H]− Calc. | Error | RDB | MS/MS Fragment Ions ( |
|---|---|---|---|---|---|---|---|---|
|
| 2.420 | C9H8O3 | 163.0407 | 163.0401 | 3.9 | 6 | 119.0508; 117.0348; 93.0351 | |
|
| 2.557 | Quercetin rutinoside | C27H30O16 | 609.1464 | 609.1461 | 0.5 | 13 | 301.0349; 300.0275; 271.0247; 255.0297 |
|
| 2.674 | Quercetin hexoside | C21H20O12 | 463.0871 | 463.0882 | −2.4 | 12 | 301.0347; 300.0279; 271.0241; 255.0298; 151.0026 |
|
| 2.791 | Kaempferol rutinoside | C27H30O15 | 593.1520 | 593.1512 | 1.4 | 13 | 285.0407; 284.0327; 255.0296 |
|
| 2.85 | (iso)rhamnetin rutinoside | C28H32O16 | 623.1620 | 623.1618 | 0.4 | 13 | 315.0519; 314.0435; 300.0279; 299.0204; 271.0248 |
|
| 2.928 | Quercetin deoxyhexoside | C21H20O11 | 447.0929 | 447.0933 | −0.9 | 12 | 301.0350; 300.0274; 271.0245; 255.0298; 243.0300 |
|
| 3.240 | Kaempferol deoxyhexoside | C21H20O10 | 431.0984 | 431.0984 | 0.1 | 12 | 285.0413; 284.0326; 255.0303; 227.0350 |
|
| 3.530 | Cartamidin | C15H12O6 | 287.0560 | 287.0561 | −0.4 | 10 | 151.0027; 135.0449; 134.0371 |
|
| 3.630 | Quercetin | C15H10O7 | 301.0351 | 301.0354 | −0.9 | 11 | 273.0406; 245.0448; 227.0351; 178.9982; 151.0037; 121.0295; 107.0141 |
|
| 3.668 | Oxo-dihydroxyoctadecenoic acid hexoside | C24H42O10 | 489.2708 | 489.2705 | 0.6 | 4 | 327.2179; 291.1973; 229.1445; 211.1338; 171.1026 |
|
| 4.174 | Trihydroxyoctadecadienoic acid 1 | C18H32O5 | 327.2177 | 327.2177 | 0.0 | 3 | 309.2078; 291.1966; 229.1448; 211.1347; 183.1396; 171.1034; 165.1290; 137.0977 |
|
| 4.405 | Trihydroxyoctadecenoic acid | C18H34O5 | 329.2335 | 329.2333 | 0.5 | 2 | 311.2232; 293.2124; 229.1449; 211.1347; 183.1396; 171.1029; 127.1130 |
|
| 4.521 | n.i. | C18H32O5 | 327.2174 | 327.2177 | −0.9 | 3 | 291.1970; 239.1655; 221.1546; 197.1181; 195.1390; 179.1437 |
|
| 4.690 | n.i. | C13H18O4 | 237.1137 | 237.1132 | 2.0 | 5 | 217.0877; 193.1242; 177.0927; 165.0925; 133.1024 |
|
| 5.222 | n.i. | C25H38O6 | 433.2600 | 433.2596 | 1.0 | 7 | 327.2184; 291.1967; 229.1441; 211.1337; 201.1123; 183.1388; 171.1023 |
|
| 5.320 | Trihydroxyoctadecadienoic acid 2 | C18H32O5 | 327.2177 | 327.2177 | −0.3 | 3 | 309.2078; 291.1967; 283.1931; 265.1820; 239.1643; 211.1336; 183.1387; 171.1025; 135.0455 |
|
| 5.533 | Dihydroxyoctadecadienoic acid | C18H32O4 | 311.2232 | 311.2228 | 1.3 | 3 | 293.2128; 275.2018; 235.1702; 223.1706; 201.1134; 199.0974; 171.1025; 165.0919; 155.1078; 127.1129; 125.0974 |
|
| 5.726 | n.i. | C24H34O6 | 417.2288 | 417.2283 | 1.3 | 8 | 373.2402; 301.2179; 259.1711 |
|
| 5.803 | n.i. | C17H26O4 | 293.1764 | 293.1758 | 1.9 | 5 | 249.1863; 193.1599; 192.1160; 177.0922; 136.0897; 121.0657 |
|
| 5.899 | Dihydroxyoctadecenoic acid 1 | C18H34O4 | 313.2388 | 313.2384 | 1.2 | 2 | 295.2287; 277.2175; 201.1135; 195.1393; 183.1393; 129.0921; 99.0818 |
|
| 5.956 | Dihydroxyoctadecenoic acid 2 | C18H34O4 | 313.2392 | 313.2384 | 2.4 | 2 | 295.2285; 277.2177; 201.1135; 199.0975; 171.1029; 165.0922; 155.1082; 127.1133; 125.0974 |
|
| 6.494 | Hydroxyoctadecatrienoic acid | C18H30O3 | 293.2126 | 293.2122 | 1.3 | 4 | 275.2022; 223.1334; 205.1219; 195.1387; 183.1383; 171.1023; 121.1020 |
|
| 7.985 | Hydroxypalmitic acid | C16H32O3 | 271.2283 | 271.2279 | 1.6 | 1 | 253.2175; 225.2228; 223.2070; 221.1912; 197.1909 |
|
| 8.187 | Linolenic acid | C18H30O2 | 277.2179 | 277.2173 | 2.1 | 4 | 259.2089; 127.0774 |
|
| 8.665 | Linoleic acid | C18H32O2 | 279.2334 | 279.2330 | 1.6 | 3 | 261.2227 |
|
| 9.023 | Palmitic acid | C16H32O2 | 255.2337 | 255.2330 | 2.9 | 1 | 237.2214; 201.8350; 166.8665 |
Rt= retention time; [M−H] found () = deprotonated ions experimentally observed in TOF-MS spectra (m/z of the monoisotopic peaks); [M−H] () = theoretical deprotonated ions for a given molecular formula (m/z of the monoisotopic peaks); error (ppm) = mass error of an assignment, obtained comparing a theoretical m/z and an experimentally observed m/z (accepted values < 5 ppm); RDB = Rings and Double Bonds (conventional measure of the degree of unsaturation); n.i. = not identified.
Figure 1XIC chromatograms of phenols and polyphenols tentatively identified in ZLF-O fraction.
Figure 2XIC chromatograms of fatty acids tentatively identified in ZLF-O fraction.
Figure 3(A) DPPH• and (B) ABTS●+ Radical Scavenging Capacity (RSC, %). Values, reported as percentage vs. blank, are the mean ± SD of measurements carried out on 3 samples (n = 3) analyzed three times.
Figure 4ZLF-A enriched emulsion (A); Radical Scavenging Capacity (RSC, %) of ZLF-A enriched emulsion (B) and ZLF-O enriched emulsion (C) towards DPPH radical (■) and ABTS radical cation (○). Values, reported as percentage vs. a blank, are the mean ± SD. Representative microscopy images of ZLF-A enriched emulsion stored at 4 °C, 25 °C and 40 °C (D). Images were acquired by Nikon Eclipse TE300 microscope.
Figure 5Mitochondrial redox activity inhibition (RAI %) estimated by MTT test in HaCat cell line treated with increasing doses (25.0, 50.0, 100.0, 200.0, 300.0 and 500.0 μg/mL) of (A) ZLF-O and (B) ZLF-A extracts. Values, reported as percentage vs. an untreated control, represent mean ± standard deviation (SD) of measurements carried out in 3 samples (n = 3) analyzed twelve times.
Figure 6Mitochondrial redox activity (RA (%)) estimated by MTT test in Episkin™ reconstructed human epidermis exposed to ZLF-A crude extract and ZLF-A-enriched cosmeceutical formulation.
Figure 7Histology of EpiSkin after exposure to ZLF-A (0.10%w/w)-enriched cream (A), ZLF-A extract (B), Triton ×100 (C); negative control). Hematoxilin-Eosin staining. ×400.
Figure 8Extraction/fractionation scheme of Cucurbita pepo cv. ‘Lungo Fiorentino’. UA-M = Ultrasound Assisted Maceration; LLE = Liquid-Liquid Extraction.
Information dependent acquisition (IDA) parameters applied in HR MS/MS analysis.
| ZLF-O | ZLF-A | |
|---|---|---|
|
| 100–1500 Da | 250–950 Da |
|
| 250 ms | 250 ms |
|
| 80–1250 Da | 100–800 Da |
|
| 100 ms | 100 ms |
|
| 45 V | 35 V |
|
| 15 V | 25 V |
|
| 60 V | 70 V |